Skip to main content

Advertisement

Advertisement

Explore journals
Get published
About BMC
My account

Search all BMC articles

Article metrics
Last updated: Sat, 4 May 2024 18:14:23 Z

Safety of targeting ROR1 for cancer immunotherapy with chimeric antigen receptor-modified T cells in a primate model

Read more on our blogs
Receive BMC newsletters
Manage article alerts
Language editing for authors
Scientific editing for authors

Policies
Accessibility
Press center

Support and Contact
Leave feedback
Careers

Follow BMC

BMC Twitter page
BMC Facebook page
BMC Weibo page

By using this website, you agree to our Terms and Conditions, Your US state privacy rights, Privacy statement and Cookies policy. Your privacy choices/Manage cookies we use in the preference centre.

© 2024 BioMed Central Ltd unless otherwise stated. Part of Springer Nature.